Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.King Pharmaceuticals to begin cash tender offer for Alpharma
This offer represents a 67% premium over the closing price of Alpharma class A common stock on August 4, 2008, the date of King’s initial private written proposal
This offer represents a 67% premium over the closing price of Alpharma class A common stock on August 4, 2008, the date of King’s initial private written proposal
Under the terms of the 10 year agreement, Akorn will be responsible for the development, manufacturing and supply of two new ophthalmic products. Akorn estimates annual manufacturing revenue
The revocation was the result of an opposition proceeding brought by Trubion and several other parties. The opposition division ruled that the patent as granted did not meet
Zev Helfer, the company’s co-founder and former president and CEO, will take over the role of executive vice president, worldwide marketing and sales, in order to better focus
According to the company, its Radix Isatidis dispersible tablets, a herbal-based traditional Chinese medicine, received the highest number of orders, over 60% of the total value of the
Under the terms of the agreement, IsoSciences will be the exclusive provider to Aldrich for their stable isotope products listed in the agreement. These products include deuterated, 13C
CryoLife began distributing Hemostase MPH in the US, the UK and Germany in the second quarter of 2008. Distribution in other markets outside the US is planned for
Under the terms of the agreement, China Sky One Medical’s wholly owned subsidiary, Harbin Tian Di Ren Medical Science and Technology Company, acquired 100% of Jin Chuang’s assets
This Phase II study is designed to determine if IT-101 treatment initiated after a standard second line course of platinum chemotherapy in patients who have stable disease, a
The remaining members of the board of directors, consisting of Robert Duggan and James Knighton, appointed Minesh Mehta and Glenn Rice to the board. The board further intends